Phreesia, Inc.

PHR

Phreesia, Inc.

PHR

Insider Sentiment (TTM):

Last Purchase:2026-04-02Last Sale:2026-06-25Shares Purchased (TTM):886,245Shares Sold (TTM):167,098

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:53,274,748Shares Outstanding:60,944,962Institutional Ownership Pct.:87.41%

Earnings Market Reaction:

Filing Date:2026-05-28Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	-	74	106	98	91	84	82	82	80	88	103	128
Cash Cash Equivalents Restricted Cash And Restrict…	75	-	-	-	91	-	-	-	-	-	-	-
Settlement Assets Current	33	33	25	29	33	29	25	25	30	28	24	25
Accounts Receivable Net Current	90	97	88	77	75	74	71	61	66	65	57	54
Interest Receivable	1	1	-	-	-	0	-	-	-	-	-	-
Capitalized Contract Cost Net Current	0	0	0	0	0	0	0	1	1	1	1	1
Prepaid Expense And Other Assets Current	16	18	20	18	16	16	11	12	14	14	14	12
Assets Current	267	280	241	223	215	203	190	181	191	196	199	219
Property Plant And Equipment And Finance Lease Rig…	21	20	21	23	23	24	26	21	22	17	20	23
Capitalized Computer Software Net	55	54	54	54	54	53	51	50	48	46	44	41
Operating Lease Right Of Use Asset	2	2	1	1	1	1	2	2	1	0	0	0
Capitalized Contract Cost Net Noncurrent	0	0	0	1	0	1	0	1	1	1	1	1
Finite Lived Intangible Assets Net	77	80	26	26	27	28	29	30	31	32	33	13
Goodwill	170	170	76	76	76	76	76	76	76	76	75	41
Deferred Income Tax Assets Net	2	2	2	2	-	0	-	-	-	0	0	0
Other Assets Noncurrent	7	2	3	4	3	3	2	2	3	3	2	2
Assets	666	664	423	409	400	388	376	362	372	370	375	340
Liabilities And Stockhold…
Liabilities Current
Settlement Liabilities Current	33	33	25	29	33	29	25	25	30	28	24	25
Long Term Debt And Capital Lease Obligations Curre…	5	8	6	7	8	8	9	7	8	6	7	7
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	0	1	0
Accounts Payable Current	12	11	6	7	3	6	16	7	7	8	11	8
Accrued Liabilities Current	31	41	31	35	34	37	29	33	33	37	28	28
Contract With Customer Liability Current	40	50	30	27	31	33	22	21	24	24	22	16
Other Liabilities Current	1	1	-	-	-	0	7	8	6	6	6	-
Liabilities Current	152	183	99	105	111	114	109	102	108	110	98	85
Long Term Debt And Capital Lease Obligations	85	92	3	5	6	8	10	7	9	5	7	8
Operating Lease Liability Noncurrent	1	1	0	0	0	1	1	1	1	0	0	0
Contract With Customer Liability Noncurrent	3	0	0	0	0	0	0	0	0	0	0	0
Deferred Tax And Other Liabilities Noncurrent	5	4	1	1	1	0	0	0	0	0	0	0
Other Liabilities Noncurrent	0	0	0	0	0	0	0	0	1	3	4	-
Liabilities	307	327	103	111	118	124	121	111	119	119	110	93
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	-	-
Common Stock Value	1	1	1	1	1	1	1	1	1	1	1	1
Additional Paid In Capital	1,202	1,182	1,166	1,148	1,132	1,111	1,095	1,077	1,060	1,039	1,022	971
Retained Earnings Accumulated Deficit	-796	-799	-800	-805	-805	-801	-795	-781	-763	-743	-712	-680
Accumulated Other Comprehensive Income Loss Net Of…	-1	-0	-0	0	0	-0	-0	-0	0	0	-	-
Treasury Stock Common Value	-47	-46	-46	-46	-46	-46	-46	-46	-46	-46	-46	-44
Stockholders Equity	359	337	320	298	282	265	255	251	253	251	265	247
Liabilities And Stockholders Equity	666	664	423	409	400	388	376	362	372	370	375	340
Restricted Cash	0	-	-	-	-	-	-	-	-	-	-	-
Allowance For Doubtful Accounts Receivable Current	1	2	2	3	2	1	1	1	1	1	2	1
Property Plant And Equipment And Finance Lease Rig…	90	94	94	91	87	85	88	84	80	77	73	68
Capitalized Computer Software Accumulated Amortiza…	73	69	66	62	59	56	53	51	48	46	44	42
Finite Lived Intangible Assets Accumulated Amortiz…	16	13	11	10	9	8	8	7	6	5	4	3
Restricted Cash Noncurrent	2	-	-	-	-	-	-	-	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	-	-
Preferred Stock Shares Authorized	20	20	20	20	20	20	20	20	20	20	-	-
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	-	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	-	-
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	500	500	500	500	500	500	500	500	500	500	500	500
Common Stock Shares Issued	63	62	62	61	61	60	59	59	59	58	57	55
Treasury Stock Common Shares	1	1	1	1	1	1	1	1	1	1	1	1

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2027	-0.74%	13.33%	-	-	-	-	-	-	-	-	-	-
2026	12.49%	9.36%	23.18%	-16.03%	-16.53%	-28.72%	5.64%	-12.96%	-20.09%	13.84%	6.44%	11.93%
2025	7.03%	21.14%	28.17%	-11.56%	-28.96%	-22.65%	21.13%	31.58%	22.70%	-4.48%	1.06%	-3.77%
2024	-1.65%	0.52%	-12.11%	-20.98%	-47.34%	-33.63%	29.47%	41.22%	35.46%	-8.25%	-6.02%	-20.34%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31
Liquidity Ratios
Current Ratio	1.76	1.53	2.44	2.12	1.95	1.78	1.74	1.77	1.76	1.78	2.02	2.58
Quick Ratio	1.65	1.43	2.23	1.94	1.80	1.64	1.64	1.66	1.63	1.65	1.89	2.45
Working Capital	115.15M	96.60M	142.12M	117.51M	104.69M	89.26M	80.37M	78.93M	82.62M	85.57M	100.82M	134.36M
Leverage & Debt
Debt to Equity	0.86	0.97	0.32	0.37	0.42	0.47	0.48	0.44	0.47	0.47	0.42	0.38
Interest Coverage TTM	1.04	-4.65	-6.01	-24.13	-79.78	-176.05	-161.74	-99.06	-68.13	-61.73	-40.54	-48.93
Debt Ratio	0.46	0.49	0.24	0.27	0.30	0.32	0.32	0.31	0.32	0.32	0.29	0.27
Efficiency & Turnover
Asset Turnover TTM	0.93	0.91	1.16	1.17	1.13	1.11	1.08	1.11	1.03	0.96	0.88	0.83
Days Sales Outstanding TTM	60.65	64.96	62.91	56.05	59.37	60.20	58.04	53.91	58.21	59.55	54.98	57.64
Receivables Turnover TTM	6.02	5.62	5.80	6.51	6.15	6.06	6.29	6.77	6.27	6.13	6.64	6.33
Per Share Metrics
Diluted EPS TTM	0.15	0.04	-0.09	-0.39	-0.73	-1.02	-1.43	-1.74	-2.10	-2.51	-2.61	-2.83
Free Cash Flow Per Share TTM	1.25	1.13	0.83	0.72	0.62	0.41	0.08	-0.14	-0.44	-0.70	-0.89	-1.19
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	85.39%	85.15%	85.13%	84.79%	84.55%	84.22%	83.74%	83.71%	83.45%	82.87%	82.24%	81.51%
Operating Profit Margin TTM	0.69%	-1.38%	-1.87%	-5.84%	-9.66%	-13.84%	-19.76%	-25.20%	-31.58%	-38.30%	-43.42%	-48.37%
Net Profit Margin TTM	1.85%	0.48%	-1.16%	-5.35%	-9.83%	-13.94%	-20.43%	-25.73%	-31.87%	-38.42%	-42.70%	-47.75%
Growth Metrics
Net Revenue Growth (1Y)	14.05%	14.48%	14.33%	15.31%	16.29%	17.83%	19.91%	22.10%	23.98%	26.84%	28.79%	30.27%
Net Income Growth (1Y)	-121.50%	-103.94%	-93.50%	-76.02%	-64.12%	-57.24%	-42.62%	-34.21%	-26.69%	-22.29%	-21.84%	-15.64%
EPS Growth (1Y)	-120.78%	-103.80%	-93.73%	-76.86%	-65.50%	-59.49%	-45.23%	-38.45%	-30.99%	-25.31%	-25.58%	-17.94%
Valuation Metrics
P/E TTM	61.12	347.91	-252.57	-66.79	-34.43	-28.00	-12.79	-14.30	-9.87	-10.16	-5.23	-11.19
P/B TTM	1.56	2.38	4.24	5.39	5.21	6.19	4.16	5.71	4.65	5.53	2.85	6.91
P/S TTM	1.13	1.67	2.93	3.57	3.38	3.90	2.61	3.68	3.15	3.90	2.23	5.34
Market Cap	561.30M	802.28M	1.36B	1.61B	1.47B	1.64B	1.06B	1.43B	1.18B	1.39B	754.73M	1.71B
Enterprise Value	575.51M	828.54M	1.26B	1.52B	1.39B	1.57B	996.26M	1.37B	1.11B	1.31B	664.96M	1.59B
Calculated Values
Free Cash Flow TTM	75.98M	67.71M	50.08M	43.05M	36.62M	23.67M	4.67M	-8.06M	-24.78M	-38.18M	-49.25M	-63.84M
Net Debt	14.21M	26.26M	-96.82M	-86.59M	-76.36M	-68.03M	-62.58M	-67.34M	-63.09M	-76.06M	-89.77M	-112.51M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-25Sale

Owner: Egbuonu-Davis, Lisa

Title: -

Shares: 2,546

Price/Share: $9.53

Value: $24,263.38

Shares Owned: 38,316

Relationship: Director

Ownership: Direct

2026-05-18Sale

Owner: Hui, Yvonne

Title: Principal Accounting Officer

Shares: 431

Price/Share: $8.85

Value: $3,814.35

Shares Owned: 24,233

Relationship: Officer

Ownership: Direct

2026-04-20Sale

Owner: Hoffman, Allison C

Title: General Counsel & Secretary

Shares: 6,176

Price/Share: $9.06

Value: $55,954.56

Shares Owned: 157,309

Relationship: Officer

Ownership: Direct

2026-04-17Sale

Owner: Hui, Yvonne

Title: Principal Accounting Officer

Shares: 1,327

Price/Share: $9.28

Value: $12,314.56

Shares Owned: 24,664

Relationship: Officer

Ownership: Direct

2026-04-16Sale

Owner: Hui, Yvonne

Title: Principal Accounting Officer

Shares: 10,063

Price/Share: $9.08

Value: $91,372.04

Shares Owned: 25,991

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-25	Egbuonu-Davis, Lisa	Director	-	Direct	Sale	2,546	9.53	$24,263.38	38,316	4
2026-05-18	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	431	8.85	$3,814.35	24,233	4
2026-04-20	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	6,176	9.06	$55,954.56	157,309	4
2026-04-17	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	1,327	9.28	$12,314.56	24,664	4
2026-04-16	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	10,063	9.08	$91,372.04	25,991	4
2026-04-10	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	14,483	8.07	$116,877.81	163,485	4
2026-04-10	Linetsky, David	Officer	President, Network Solutions	Direct	Sale	8,332	8.07	$67,239.24	224,056	4
2026-04-02	Barta, Jan, Senkypl Dusan…	TenPercentOwner	-	Indirect	Purchase	106,236	8.31	$882,821.16	8,924,329	4
2026-03-25	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	3,829	11.26	$43,114.54	146,740	4
2026-03-23	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	6,176	11.97	$73,926.72	163,485	4
2026-03-19	Pale, Fire Capital Sicav …	TenPercentOwner	-	Indirect	Purchase	780,009	11.69	$9,118,305.21	7,648,829	4
2026-03-18	Linetsky, David	Officer	President, Network Solutions	Indirect	Sale	107	11.06	$1,183.42	11,068	4
2026-01-16	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	4,687	16.36	$76,679.32	150,569	4
2026-01-16	Linetsky, David	Officer	President, Network Solutions	Direct	Sale	6,038	16.36	$98,781.68	223,942	4
2026-01-16	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	3,995	16.36	$65,358.20	169,661	4
2026-01-16	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	9,595	16.36	$156,974.20	1,361,535	4
2026-01-16	Roberts, Evan	Officer	President, Provider Solutions	Direct	Sale	6,268	16.36	$102,544.48	826,554	4
2026-01-16	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	2,202	16.36	$36,024.72	157,349	4
2026-01-15	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	379	16.17	$6,128.43	29,166	4
2026-01-08	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	6,585	17.01	$112,010.85	174,762	4
2026-01-08	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	8,009	17.01	$136,233.09	156,231	4
2026-01-08	Roberts, Evan	Officer	President, Provider Solutions	Direct	Sale	6,317	17.01	$107,452.17	834,632	4
2026-01-08	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	2,602	17.01	$44,260.02	160,238	4
2026-01-08	Linetsky, David	Officer	President, Network Solutions	Direct	Sale	6,106	17.01	$103,863.06	231,723	4
2026-01-08	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	8,440	17.01	$143,564.40	1,374,168	4
2026-01-08	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	372	17.47	$6,498.84	29,910	4
2025-12-17	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	426	16.25	$6,922.50	29,910	4
2025-12-17	Linetsky, David	Officer	President, Network Solutions	Indirect	Sale	94	16.49	$1,550.06	9,789	4
2025-10-17	Linetsky, David	Officer	President, Network Solutions	Direct	Sale	2,059	22.36	$46,039.24	171,829	4
2025-10-17	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	3,163	22.36	$70,724.68	1,252,608	4
2025-10-17	Roberts, Evan	Officer	President, Provider Solutions	Direct	Sale	1,888	22.36	$42,215.68	724,949	4
2025-10-17	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	885	22.36	$19,788.60	98,240	4
2025-10-17	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	1,241	22.36	$27,748.76	135,737	4
2025-10-17	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	639	22.36	$14,288.04	111,840	4
2025-10-15	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	302	23.05	$6,961.10	30,336	4
2025-09-18	Linetsky, David	Officer	President, Network Solutions	Indirect	Sale	93	23.94	$2,226.42	9,883	4
2025-09-17	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	2,059	23.50	$48,386.50	136,978	4
2025-09-17	Linetsky, David	Officer	President, Network Solutions	Direct	Sale	1,064	23.50	$25,004.00	173,888	4
2025-09-16	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	4,183	23.28	$97,380.24	99,125	4
2025-09-16	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	1,762	23.28	$41,019.36	112,479	4
2025-09-16	Roberts, Evan	Officer	President, Provider Solutions	Direct	Sale	3,761	23.28	$87,556.08	726,837	4
2025-09-16	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	6,328	23.28	$147,315.84	1,255,771	4
2025-09-16	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	940	23.28	$21,883.20	30,638	4
2025-08-28	Roberts, Evan	Officer	President, Provider Solutions	Direct	Sale	3,400	32.46	$110,364.00	724,368	4
2025-08-28	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	7,746	32.47	$251,512.62	1,251,403	4
2025-08-25	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	18,573	30.37	$564,062.01	110,607	4
2025-08-25	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	9,583	30.01	$287,585.83	97,078	4
2025-08-25	Weintraub, Michael	Director	-	Direct	Sale	10,000	30.00	$300,000.00	158,229	4
2025-08-22	Linetsky, David	Officer	President, Network Solutions	Direct	Sale	17,445	29.73	$518,639.85	174,002	4
2025-08-18	Linetsky, David	Officer	President, Network Solutions	Indirect	Sale	78	29.16	$2,274.48	9,717	4
2025-07-18	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	626	26.23	$16,419.98	29,190	4
2025-07-17	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	640	26.89	$17,209.60	129,180	4
2025-07-17	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	1,245	26.89	$33,478.05	136,978	4
2025-07-17	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	886	26.89	$23,824.54	106,661	4
2025-07-17	Linetsky, David	Officer	SVP, Network Solutions	Direct	Sale	2,063	26.89	$55,474.07	191,447	4
2025-07-17	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	1,892	26.89	$50,875.88	772,915	4
2025-07-17	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	3,171	26.89	$85,268.19	1,251,403	4
2025-07-16	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	422	26.95	$11,372.90	30,281	4
2025-07-15	Egbuonu-Davis, Lisa	Director	-	Direct	Sale	465	27.64	$12,852.60	21,572	4
2025-07-07	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	571	28.85	$16,473.35	31,010	4
2025-07-02	Smith, Mark Douglas	Director	-	Direct	Sale	7,000	29.00	$203,000.00	37,353	4
2025-06-27	Linetsky, David	Officer	SVP, Network Solutions	Direct	Sale	23,729	28.50	$676,276.50	193,510	4
2025-06-26	Egbuonu-Davis, Lisa	Director	-	Direct	Sale	2,802	27.67	$77,531.34	22,037	4
2025-06-18	Linetsky, David	Officer	SVP, Network Solutions	Indirect	Sale	67	25.61	$1,715.87	9,795	4
2025-06-10	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	582	28.00	$16,296.00	31,010	4
2025-06-10	Weintraub, Michael	Director	-	Direct	Sale	2,569	27.86	$71,572.34	143,039	4
2025-04-22	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	1,330	23.70	$31,521.00	22,592	4
2025-04-21	Linetsky, David	Officer	SVP, Life Sciences	Indirect	Sale	260	23.04	$5,990.40	8,752	4
2025-04-16	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	864	23.81	$20,571.84	107,547	4
2025-04-16	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	1,213	23.81	$28,881.53	137,921	4
2025-04-16	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	1,845	23.81	$43,929.45	774,807	4
2025-04-16	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	3,091	23.81	$73,596.71	1,254,574	4
2025-04-16	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	418	23.66	$9,889.88	24,915	4
2025-04-16	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	4,499	23.74	$106,806.26	217,239	4
2025-04-16	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	624	23.81	$14,857.44	129,820	4
2025-04-09	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	2,802	23.23	$65,090.46	25,647	4
2025-04-09	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	4,696	23.23	$109,088.08	139,134	4
2025-04-08	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	3,944	23.97	$94,537.68	221,738	4
2025-04-08	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	1,695	23.97	$40,629.15	130,444	4
2025-04-08	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	12,167	23.97	$291,642.99	1,257,665	4
2025-04-08	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	8,045	23.97	$192,838.65	108,411	4
2025-04-08	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	7,233	23.97	$173,375.01	776,652	4
2025-03-26	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	1,827	27.46	$50,169.42	103,591	4
2025-03-19	Linetsky, David	Officer	SVP, Life Sciences	Indirect	Sale	88	28.08	$2,471.04	8,724	4
2025-03-17	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	3,496	25.32	$88,518.72	139,134	4
2025-02-19	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	96	30.00	$2,880.00	105,418	4
2025-02-19	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	177	30.00	$5,310.00	741,020	4
2025-02-18	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	3,496	29.72	$103,901.12	142,630	4
2025-02-14	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	4,889	30.09	$147,110.01	111,285	4
2025-02-14	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	3,586	30.13	$108,046.18	744,716	4
2025-02-13	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	11,616	29.70	$344,995.20	218,135	4
2025-02-07	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	300	29.52	$8,856.00	229,751	4
2025-02-05	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	720	29.50	$21,240.00	230,051	4
2025-01-29	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	500	29.68	$14,840.00	230,771	4
2025-01-28	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	6,235	28.50	$177,697.50	146,126	4
2025-01-27	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	10,716	27.66	$296,404.56	764,307	4
2025-01-27	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	26,248	27.66	$726,019.68	1,260,200	4
2025-01-27	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	4,813	27.66	$133,127.58	144,933	4
2025-01-27	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	3,475	27.66	$96,118.50	114,734	4
2025-01-27	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	11,685	27.66	$323,207.10	231,271	4
2025-01-24	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	127	28.00	$3,556.00	25,647	4
2025-01-21	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	8,426	27.31	$230,114.06	146,126	4
2025-01-21	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	21,692	27.31	$592,408.52	1,237,538	4
2025-01-21	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	13,873	27.31	$378,871.63	223,392	4
2025-01-21	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	12,749	27.31	$348,175.19	755,459	4
2025-01-21	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	5,827	27.31	$159,135.37	141,846	4
2025-01-21	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	4,720	27.31	$128,903.20	110,309	4
2025-01-15	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	604	26.98	$16,295.92	115,029	4
2025-01-15	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	1,785	26.98	$48,159.30	768,208	4
2025-01-15	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	2,990	26.98	$80,670.20	1,259,230	4
2025-01-15	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	4,585	26.92	$123,428.20	154,552	4
2025-01-15	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	1,946	26.98	$52,503.08	237,265	4
2025-01-15	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	381	26.87	$10,237.47	25,774	4
2025-01-15	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	836	26.98	$22,555.28	147,673	4
2025-01-14	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	362	26.38	$9,549.56	26,155	4
2025-01-10	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	388	27.85	$10,805.80	26,517	4
2025-01-08	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	288	28.00	$8,064.00	26,905	4
2025-01-08	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	2,681	28.07	$75,255.67	769,993	4
2025-01-07	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	7,319	27.00	$197,613.00	772,674	4
2025-01-06	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	3,195	26.61	$85,018.95	148,509	4
2025-01-06	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	5,375	26.61	$143,028.75	1,262,220	4
2025-01-06	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	1,311	26.61	$34,885.71	115,633	4
2025-01-06	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	3,133	26.61	$83,369.13	239,211	4
2025-01-06	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	3,982	26.61	$105,961.02	159,137	4
2024-12-18	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	3,495	24.88	$86,955.60	116,296	4
2024-12-18	Linetsky, David	Officer	SVP, Life Sciences	Indirect	Sale	24	25.38	$609.12	8,851	4
2024-12-17	Linetsky, David	Officer	SVP, Life Sciences	Indirect	Sale	61	25.40	$1,549.40	8,875	4
2024-12-16	Weintraub, Michael	Director	-	Direct	Sale	861	25.26	$21,748.86	242,827	4
2024-12-11	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	11,853	24.85	$294,547.05	188,354	4
2024-12-11	Weintraub, Michael	Director	-	Direct	Sale	18,574	25.10	$466,207.40	242,827	4
2024-12-10	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	25,000	24.09	$602,250.00	728,876	4
2024-12-03	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	25,447	20.93	$532,605.71	93,470	4
2024-12-02	Weintraub, Michael	Director	-	Direct	Sale	15,152	21.01	$318,343.52	242,827	4
2024-10-18	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	1,100	20.49	$22,539.00	200,207	4
2024-10-16	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	423	21.33	$9,022.59	26,805	4
2024-10-15	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	864	21.03	$18,169.92	97,714	4
2024-10-15	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	3,089	21.03	$64,961.67	1,220,647	4
2024-10-15	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	1,843	21.03	$38,758.29	753,876	4
2024-10-15	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	2,011	21.03	$42,291.33	201,307	4
2024-10-15	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	624	21.03	$13,122.72	118,917	4
2024-10-15	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	1,212	21.03	$25,488.36	119,791	4
2024-09-19	Linetsky, David	Officer	SVP, Life Sciences	Indirect	Sale	24	24.04	$576.96	8,971	4
2024-09-18	Linetsky, David	Officer	SVP, Life Sciences	Indirect	Sale	61	24.09	$1,469.49	8,995	4
2024-09-12	Egbuonu-Davis, Lisa	Director	-	Direct	Sale	1,400	23.03	$32,242.00	18,139	4
2024-09-11	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	2,072	23.36	$48,401.92	121,003	4
2024-09-10	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	1,716	23.25	$39,897.00	203,318	4
2024-09-10	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	737	23.25	$17,135.25	119,541	4
2024-09-10	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	744	23.25	$17,298.00	30,019	4
2024-09-10	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	5,295	23.25	$123,108.75	1,223,736	4
2024-09-10	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	3,502	23.25	$81,421.50	98,578	4
2024-09-10	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	3,148	23.25	$73,191.00	755,719	4
2024-08-26	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	14,110	26.03	$367,283.30	121,003	4
2024-07-29	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	7	24.75	$173.25	1,219,361	4
2024-07-18	Smith, Mark Douglas	Director	-	Direct	Sale	7,000	25.00	$175,000.00	30,653	4
2024-07-16	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	1,820	23.74	$43,206.80	202,218	4
2024-07-16	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	783	23.74	$18,588.42	96,447	4
2024-07-16	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	800	23.74	$18,992.00	135,113	4
2024-07-16	Hui, Yvonne	Officer	Principal Accounting Officer	Direct	Sale	283	23.74	$6,718.42	28,714	4
2024-07-16	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	1,669	23.74	$39,622.06	753,234	4
2024-07-16	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	2,644	23.74	$62,768.56	1,219,361	4
2024-07-16	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	374	23.74	$8,878.76	118,636	4
2024-06-21	Linetsky, David	Officer	SVP, Life Sciences	Indirect	Sale	27	20.24	$546.48	6,953	4
2024-06-21	Gunzburg, Janet	Officer	Principal Accounting Officer	Direct	Sale	114	20.24	$2,307.36	34,820	4
2024-06-20	Linetsky, David	Officer	SVP, Life Sciences	Indirect	Sale	66	19.73	$1,302.18	6,980	4
2024-05-01	Gunzburg, Janet	Officer	Principal Accounting Officer	Direct	Sale	286	21.00	$6,006.00	34,934	4
2024-04-18	Gunzburg, Janet	Officer	Principal Accounting Officer	Direct	Sale	912	22.85	$20,839.20	35,220	4
2024-04-18	Linetsky, David	Officer	SVP, Life Sciences	Indirect	Sale	269	22.85	$6,146.65	7,087	4
2024-04-15	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	1,238	22.86	$28,300.68	135,621	4
2024-04-15	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	685	22.86	$15,659.10	119,010	4
2024-04-15	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	948	22.86	$21,671.28	97,230	4
2024-04-15	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	2,029	22.86	$46,382.94	754,903	4
2024-04-15	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	3,392	22.86	$77,541.12	1,222,005	4
2024-04-15	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	2,212	22.86	$50,566.32	204,038	4
2024-04-10	Gunzburg, Janet	Officer	Principal Accounting Officer	Direct	Sale	2,768	23.10	$63,940.80	36,132	4
2024-04-09	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	4,626	23.42	$108,340.92	136,859	4
2024-04-09	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	3,768	23.43	$88,284.24	119,695	4
2024-04-08	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	3,914	22.82	$89,317.48	206,250	4
2024-04-08	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	7,778	22.82	$177,493.96	98,178	4
2024-04-08	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	12,043	22.82	$274,821.26	1,225,397	4
2024-04-08	Gunzburg, Janet	Officer	Principal Accounting Officer	Direct	Sale	1,709	22.82	$38,999.38	38,900	4
2024-04-08	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	7,178	22.82	$163,801.96	733,602	4
2024-03-25	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	3,504	23.21	$81,327.84	94,030	4
2024-03-21	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	25,962	23.97	$622,309.14	728,570	4
2024-03-20	Linetsky, David	Officer	SVP, Life Sciences	Indirect	Sale	30	23.66	$709.80	7,095	4
2024-03-20	Gunzburg, Janet	Officer	Principal Accounting Officer	Direct	Sale	137	23.66	$3,241.42	38,949	4
2024-03-19	Linetsky, David	Officer	SVP, Life Sciences	Indirect	Sale	402	23.27	$9,354.54	7,125	4
2024-02-09	Gunzburg, Janet	Officer	Principal Accounting Officer	Direct	Sale	480	28.00	$13,440.00	39,086	4
2024-02-02	Gunzburg, Janet	Officer	Principal Accounting Officer	Direct	Sale	480	27.00	$12,960.00	39,566	4
2024-02-01	Gunzburg, Janet	Officer	Principal Accounting Officer	Direct	Sale	328	25.99	$8,524.72	40,046	4
2024-01-17	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	63,931	24.12	$1,542,015.72	1,216,479	4
2024-01-17	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	41,081	24.12	$990,873.72	754,532	4
2024-01-17	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	9,192	24.12	$221,711.04	97,534	4
2024-01-17	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	30,659	24.12	$739,495.08	204,059	4
2024-01-17	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	10,213	24.12	$246,337.56	119,695	4
2024-01-17	Davidoff, Michael J.	Officer	SVP, Payer Business	Direct	Sale	17,677	24.12	$426,369.24	73,391	4
2024-01-17	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	7,605	24.12	$183,432.60	136,859	4
2023-12-19	Linetsky, David	Officer	SVP, Life Sciences	Indirect	Sale	25	23.72	$593.00	7,573	4
2023-12-19	Gunzburg, Janet	Officer	Principal Accounting Officer	Direct	Sale	118	23.72	$2,798.96	40,579	4
2023-12-18	Linetsky, David	Officer	SVP, Life Sciences	Indirect	Sale	100	23.15	$2,315.00	9,904	4
2023-11-01	Gunzburg, Janet	Officer	Principal Accounting Officer	Direct	Sale	298	13.38	$3,987.24	40,697	4
2023-10-16	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	665	16.61	$11,045.65	118,146	4
2023-10-16	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	1,297	16.61	$21,543.17	115,025	4
2023-10-16	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	1,971	16.61	$32,738.31	745,860	4
2023-10-16	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	3,295	16.61	$54,729.95	1,241,996	4
2023-10-16	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	861	16.61	$14,301.21	85,658	4
2023-10-16	Davidoff, Michael J.	Officer	SVP, Payer Business	Direct	Sale	1,198	16.61	$19,898.78	92,378	4
2023-10-16	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	2,078	16.61	$34,515.58	215,036	4
2023-09-18	Gunzburg, Janet	Officer	Principal Accounting Officer	Direct	Sale	125	19.79	$2,473.75	40,995	4
2023-09-18	Linetsky, David	Officer	SVP, Life Sciences	Indirect	Sale	130	19.70	$2,561.00	7,832	4
2023-09-14	Hoffman, Allison C	Officer	General Counsel & Secretary	Direct	Sale	2,210	20.17	$44,575.70	116,322	4
2023-09-14	Vanduyn, Amy Beth	Officer	SVP, Human Resources	Direct	Sale	2,000	20.16	$40,320.00	118,811	4
2023-09-14	Davidoff, Michael J.	Officer	SVP, Payer Business	Direct	Sale	2,953	20.16	$59,532.48	93,576	4
2023-09-13	Gunzburg, Janet	Officer	Principal Accounting Officer	Direct	Sale	934	20.75	$19,380.50	41,120	4
2023-09-13	Linetsky, David	Officer	SVP, Life Sciences	Direct	Sale	2,059	20.75	$42,724.25	217,114	4
2023-09-13	Indig, Chaim	Director,Officer	Chief Executive Officer	Direct	Sale	6,555	20.75	$136,016.25	1,245,291	4
2023-09-13	Roberts, Evan	Officer	Chief Operating Officer	Direct	Sale	3,907	20.75	$81,070.25	747,831	4
2023-09-13	Gandhi, Balaji	Officer	Chief Financial Officer	Direct	Sale	3,957	20.75	$82,107.75	86,519	4
2023-07-21	Davidoff, Michael J.	Officer	SVP, Payer Business	Direct	Sale	1,075	31.75	$34,131.25	93,576	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

87.41%

Inst. Shares: 53,274,748

Shares Outstanding: 60,944,962

2025-12-31

93.03%

Inst. Shares: 55,573,637

Shares Outstanding: 59,737,915

2025-09-30

96.01%

Inst. Shares: 57,615,675

Shares Outstanding: 60,008,780

2025-06-30

94.16%

Inst. Shares: 56,109,639

Shares Outstanding: 59,591,545

2025-03-31

91.01%

Inst. Shares: 53,622,495

Shares Outstanding: 58,920,782

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	53,274,748	60,944,962	87.41%
2025-12-31	55,573,637	59,737,915	93.03%
2025-09-30	57,615,675	60,008,780	96.01%
2025-06-30	56,109,639	59,591,545	94.16%
2025-03-31	53,622,495	58,920,782	91.01%
2024-12-31	51,719,982	57,589,687	89.81%
2024-09-30	51,605,578	57,891,591	89.14%
2024-06-30	50,361,814	57,502,959	87.58%
2024-03-31	47,120,733	56,666,311	83.15%
2023-12-31	45,944,244	54,561,449	84.21%
2023-09-30	45,287,340	55,251,074	81.97%
2023-06-30	43,887,044	53,794,060	81.58%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Phreesia, Inc. (PHR) — SEC Financial Statements & Analysis

Phreesia, Inc. (PHR) is a services-business services, nec company, incorporated in DE. Phreesia, Inc. trades on NYSE as: PHR. Based on its latest SEC filing (Form 10-Q, period ending 2026-04-30), Phreesia, Inc. reported a 14.05% year-over-year revenue growth, a Gross Profit Margin of 85.39% (TTM), a Debt-to-Equity ratio of 0.86x, a Price-to-Sales (P/S) ratio of 1.13x (TTM), a Price-to-Book (P/B) ratio of 1.56x (TTM), at a market cap of $561.30M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 14.05%
Gross Profit Margin TTM: 85.39%
Debt To Equity: 0.86x
P/S TTM: 1.13x
P/B TTM: 1.56x
Market Cap: $561.30M

Data as of 2026-04-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Phreesia, Inc. in?

Phreesia, Inc. (PHR) operates in the Services-Business Services, NEC industry.

What is PHR's market cap?

Phreesia, Inc. (PHR) has a market capitalization of $561.30M as of 2026-04-30.

What is PHR's P/E ratio?

Phreesia, Inc. (PHR)'s trailing twelve month P/E ratio is 61.12x as of 2026-04-30.

What exchange does PHR trade on?

Phreesia, Inc. (PHR) trades on the NYSE.

Where is Phreesia, Inc. incorporated?

Phreesia, Inc. is incorporated in DE.

Phreesia, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Phreesia, Inc. (PHR) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Services-Business Services, NEC

Wall Street's data.
Main Street's price.

Phreesia, Inc. (PHR) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Services-Business Services, NEC

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.